{{medical}}
[[File:Escitalopram_structure.svg|thumb]], 一作為[[抗憂鬱劑|抗憂鬱劑]]的[[选择性5-羟色胺再摄取抑制剂|選擇性血清素再吸收抑制劑]]]]
'''再攝取抑制劑''' (英語：'''reuptake inhibitor''')('''RI''')是一種{{le|再攝取調節劑|reuptake modulator}}，它可抑制由[[細胞膜|細胞膜]][[轉運體|轉運體]]中介的[[神經傳導物|神經傳導物]]{{le|再攝取|reuptake}}，進而增加胞膜外[[神经递质|神經傳導物]]的濃度。達成更多神經傳導. 數種[[藥物|藥物]]藉由再吸收抑制達到[[心理|心理]]和[[生理|生理]]上的作用，包括各式[[抗憂鬱劑|抗憂鬱劑]]及興奮劑<ref name="pmid16402124"><cite class="citation journal" contenteditable="false">Iversen L. (2006). </cite></ref><div>
多數已知的再吸收抑制劑影響單胺神經傳導物[[血清素|血清素]]，[[去甲肾上腺素|去甲肾上腺素]](&[[腎上腺素|腎上腺素]])及[[多巴胺|多巴胺]]。<ref name="pmid16402124"><cite class="citation journal" contenteditable="false">Iversen L. (2006). </cite></ref> 但也有不少藥品及研究用化合物作用於其他[[神经递质|神经递质]]，例如[[穀氨酸|穀氨酸]],<ref name="pmid9259454"><cite class="citation journal" contenteditable="false">West AR, Galloway MP (1997). </cite></ref>[[γ-氨基丁酸|γ-氨基丁酸]] [[Γ-氨基丁酸|(GABA)]],<ref name="pmid16420077"><cite class="citation journal" contenteditable="false">Pollack MH, Roy-Byrne PP, Van Ameringen M, Snyder H, Brown C, Ondrasik J, Rickels K (2005). </cite></ref> [[甘氨酸|甘胺酸]],<ref name="pmid22138164"><cite class="citation journal" contenteditable="false">Alberati D, Moreau JL, Lengyel J,  et al. </cite></ref>[[腺苷|腺咁]],<ref name="pmid8383814"><cite class="citation journal" contenteditable="false">Boissard CG, Gribkoff VK (1993). </cite></ref> [[胆碱|胆碱]] ([[乙酰胆碱|乙酰胆碱]][[前驅物|前驅物]]),<ref name="pmid12432531"><cite class="citation journal" contenteditable="false">Barkhimer TV, Kirchhoff JR, Hudson RA, Messer WS (November 2002). [[doi:10.1002/1522-2683(200211)23:21|<3699::AID-ELPS3699>3.0.]]</cite></ref> 及[[大麻素|大麻素]],<ref name="pmid16770320"><cite class="citation journal" contenteditable="false">Costa B, Siniscalco D, Trovato AE, Comelli F, Sotgiu ML, Colleoni M, Maione S, Rossi F, Giagnoni G (2006). </cite></ref> 
</div>

== 引用資料 ==
{{Reflist|2}}
{{Neuromodulation}}
[[Category:单胺重摄取抑制剂|Category:单胺重摄取抑制剂]]
[[Category:药效学|Category:药效学]]